Table 3.
Comparison between Egyptian and Moroccan MBC patients with regards to BRCA2 expression and histopathological characteristics
| Characteristic(N=Egypt,N=Morocco) | Egypt | Morocco | p-value |
|---|---|---|---|
| BRCA2 Status(N=45,N=18) | |||
| Wild-type | 32 (71.1%) | 13 (72.2%) | 0.9297a |
| Non-wild-type | 13 (28.9%) | 5 (27.8%) | |
| Lymph Node Involvement (N=122,N=123) | |||
| Negative | 76 (62.3%) | 76 (61.8%) | 0.9349a |
| Positive | 46 (37.7%) | 47 (38.2%) | |
| Laterality (N=152,N=127) | |||
| Right breast | 66 (43.4%) | 64 (50.4%) | 0.0967a |
| Left breast | 83 (54.6%) | 56 (44.1%) | |
| Both breasts | 3 (2.0%) | 7 (5.5%) | |
| Tumor Grade (N=116,N=84) | |||
| I | 1 (0.9%) | 9 (10.7%) | 0.0017a |
| II | 94 (81.0%) | 68 (81.0%) | |
| III | 21 (18.1%) | 7 (8.3%) | |
| ER Status (N=69,N=55) | |||
| Negative | 13 (18.8%) | 8 (14.5%) | 0.5264a |
| Positive | 56 (81.2%) | 47 (85.5%) | |
| PR Status (N=68,N=53) | |||
| Negative | 19 (27.9%) | 10 (18.9%) | 0.2461a |
| Positive | 49 (72.1%) | 43 (81.1%) | |
| Tumor Size (cm) (N=61,N=61) | 3.8 | 3.6 | 0.6845b |
| Mean AR CAG repeat Length (N=44,N=0) | 19.45 | – | – |
a
χ2-test.
b
t-test.